<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Saren T</submitter><funding>The Sjöberg Foundation</funding><funding>Vetenskapsrådet</funding><funding>Barncancerfonden</funding><funding>Cancerfonden</funding><pagination>4732</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10415375</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>Chimeric antigen receptor (CAR)-T cell therapy is rapidly advancing as cancer treatment, however, designing an optimal CAR remains challenging. A single-chain variable fragment (scFv) is generally used as CAR targeting moiety, wherein the complementarity-determining regions (CDRs) define its specificity. We report here that the CDR loops can cause CAR clustering, leading to antigen-independent tonic signalling and subsequent CAR-T cell dysfunction. We show via CARs incorporating scFvs with identical framework and varying CDR sequences that CARs may cluster on the T cell surface, which leads to antigen-independent CAR-T cell activation, characterized by increased cell size and interferon (IFN)-γ secretion. This results in CAR-T cell exhaustion, activation-induced cell death and reduced responsiveness to target-antigen-expressing tumour cells. CDR mutagenesis confirms that the CAR-clustering is mediated by CDR-loops. In summary, antigen-independent tonic signalling can be induced by CDR-mediated CAR clustering, which could not be predicted from the scFv sequences, but could be tested for by evaluating the activity of unstimulated CAR-T cells.</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Complementarity-determining region clustering may cause CAR-T cell dysfunction.</pubmed_title><pmcid>PMC10415375</pmcid><funding_grant_id>2019-01326</funding_grant_id><funding_grant_id>TJ 2019-0014</funding_grant_id><funding_grant_id>PR2020-0167</funding_grant_id><funding_grant_id>19 0184Pj</funding_grant_id><pubmed_authors>Saren T</pubmed_authors><pubmed_authors>Saronio G</pubmed_authors><pubmed_authors>Persson H</pubmed_authors><pubmed_authors>Andersson Y</pubmed_authors><pubmed_authors>Yu D</pubmed_authors><pubmed_authors>Nestor M</pubmed_authors><pubmed_authors>Marti Torrell P</pubmed_authors><pubmed_authors>Dimberg A</pubmed_authors><pubmed_authors>Thelander J</pubmed_authors><pubmed_authors>Hofstrom C</pubmed_authors><pubmed_authors>Zhu X</pubmed_authors><pubmed_authors>Ramachandran M</pubmed_authors><pubmed_authors>Essand M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Complementarity-determining region clustering may cause CAR-T cell dysfunction.</name><description>Chimeric antigen receptor (CAR)-T cell therapy is rapidly advancing as cancer treatment, however, designing an optimal CAR remains challenging. A single-chain variable fragment (scFv) is generally used as CAR targeting moiety, wherein the complementarity-determining regions (CDRs) define its specificity. We report here that the CDR loops can cause CAR clustering, leading to antigen-independent tonic signalling and subsequent CAR-T cell dysfunction. We show via CARs incorporating scFvs with identical framework and varying CDR sequences that CARs may cluster on the T cell surface, which leads to antigen-independent CAR-T cell activation, characterized by increased cell size and interferon (IFN)-γ secretion. This results in CAR-T cell exhaustion, activation-induced cell death and reduced responsiveness to target-antigen-expressing tumour cells. CDR mutagenesis confirms that the CAR-clustering is mediated by CDR-loops. In summary, antigen-independent tonic signalling can be induced by CDR-mediated CAR clustering, which could not be predicted from the scFv sequences, but could be tested for by evaluating the activity of unstimulated CAR-T cells.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2024-11-08T13:48:48.273Z</modification><creation>2024-11-08T13:48:48.273Z</creation></dates><accession>S-EPMC10415375</accession><cross_references><pubmed>37563127</pubmed><doi>10.1038/s41467-023-40303-z</doi></cross_references></HashMap>